Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in...
Disability
Navigate Expands Ecosystem to Address Caregiving and Weight Management with Homethrive and The Mayo Clinic Diet
WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion of its Partner Ecosystem, strengthening...
Navigate Expands Ecosystem to Address Caregiving and Weight Management with Homethrive and The Mayo Clinic Diet
WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion of its Partner Ecosystem, strengthening...
Apyron Pioneering Next Generation Pain Management Solutions
Atlanta, Georgia--(Newsfile Corp. - December 15, 2025) - Apyron, Inc. is a medical technology company with a product portfolio designed...
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company)...
InnoCare Announces Approval of the Next-Generation TRK Inhibitor Zurletrectinib in China
BEIJING, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that...
Careverse Launches Crowdfunding Campaign, Empowering Every Care Provider with Their Own Private AI Agent
Crowd-backed raise on Wefunder invites providers to join as users and co-owners of an AI-powered "care ecosystem," giving them back...
Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting
—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)...
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
Interim data show substantial improvements in “Good On” time compared to other oral CD/LD therapiesCREXONT delivered substantial “Off” time reductions,...
Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company...
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
Nes-Ziona, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”), today announced that...
BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ThermoFebrile Treatment
First video-documented ALS reversal marks a new era for brain health achieved through noninvasive computerized brain-temperature modulation, confirmed by electrophysiological,...
Kibu CEO Daniel Caridi Named to Forbes 30 Under 30 List for Social Impact
STAMFORD, Conn., Dec. 3, 2025 /PRNewswire/ -- Kibu, a person-centered platform for disability service providers, announced today that Co-Founder and...
Reseda Group Partners with LetMeDoIt, a First-of-Its-Kind Disability-Focused Decision-Making App
EAST LANSING, Mich., Dec. 3, 2025 /PRNewswire/ -- Reseda Group, a wholly owned credit union service organization of MSU Federal Credit...
Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results, Net profit rises 60.1% year-on-year
BEIJING, Dec. 3, 2025 /PRNewswire/ -- On December 3, 2025, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance...
Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates
Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more than 450,000...
The VA Disability System Is Failing — and Veterans Are Paying for the Gaps By Loren Ryan Hawley
Loren Ryan Hawley, Founder & CEO, Shield of Odin, discusses gaps in the VA disability system & offers supportLAS VEGAS,...
MakeGood unveils low-cost, 3D-printed toddler mobility trainer to expand access to early childhood mobility devices
NEW ORLEANS, Dec. 2, 2025 /PRNewswire/ -- MakeGood, Inc., an award-winning disability design nonprofit, has announced the launch of the 3D-Printed...
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
-- New data published in Pain Physician shows significant improvement in functional outcomes with iovera° ---- Fewer iovera° patients required...
Dr. Drew Brown Champions Non-Surgical Spine Health Awareness
Tampa-based orthopedic spine surgeon urges patients to explore holistic, evidence-based care before opting for surgery TAMPA, FL / ACCESS Newswire...